{
  "title": "The Race Gap in Clinical Trials",
  "itunes:title": "The Race Gap in Clinical Trials",
  "description": "<p>In the rush to develop a vaccine or treatment for Covid-19, drug companies are fast-tracking clinical trials. But those trials have a major diversity problem. Participants in major drug trials range from 70 percent to 89 percent white. This is a big problem, considering it’s a disease that disproportionately affects people of color. Kristen V. Brown reports that failing to account for minority groups could potentially impact how well a drug eventually works for those that the virus has harmed the most.</p><p>See <a href=\"https://omnystudio.com/listener\">omnystudio.com/listener</a> for privacy information.</p>",
  "content:encoded": "<p>In the rush to develop a vaccine or treatment for Covid-19, drug companies are fast-tracking clinical trials. But those trials have a major diversity problem. Participants in major drug trials range from 70 percent to 89 percent white. This is a big problem, considering it’s a disease that disproportionately affects people of color. Kristen V. Brown reports that failing to account for minority groups could potentially impact how well a drug eventually works for those that the virus has harmed the most.</p><p>See <a href=\"https://omnystudio.com/listener\">omnystudio.com/listener</a> for privacy information.</p>",
  "itunes:episodeType": "full",
  "itunes:season": 5,
  "itunes:episode": 86,
  "itunes:author": "Bloomberg",
  "itunes:image": "",
  "media:content": [
    {
      "media:player": ""
    },
    ""
  ],
  "guid": "6d145550-dcd3-11ea-90e2-67fc73734690",
  "omny:clipId": "d9a12625-f8e5-400e-88d3-ae390091bef4",
  "pubDate": "Wed, 12 Aug 2020 19:40:47 +0000",
  "itunes:duration": 950,
  "enclosure": "",
  "link": "https://omny.fm/shows/prognosis-breakthrough/the-race-gap-in-clinical-trials"
}